Viewing Study NCT04689360


Ignite Creation Date: 2025-12-25 @ 2:13 AM
Ignite Modification Date: 2026-03-06 @ 6:14 PM
Study NCT ID: NCT04689360
Status: AVAILABLE
Last Update Posted: 2025-02-14
First Post: 2020-12-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Intermediate Size Expanded Access Protocol of Elamipretide
Sponsor: Stealth BioTherapeutics Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mitochondrial Diseases View
None Barth Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Barth View